Did Barclays Help U.S. Banks Get Undeserved Foreign Tax Credits?
The Internal Revenue Service says STARS transactions marketed by the British bank Barclays generated undeserved foreign tax credits for six U.S. banks, which say the complex deals were legitimate low-cost loans.
Government Claims AIG 'Gamed the Tax System'
STARS deals weren't the only ones that took advantage of cross-border differences in law to reap hundreds of millions of dollars in tax breaks.
Setting The Record Straight on GE's Taxes
Did GE pay U.S. income taxes in 2010? The company known for minimizing its tax bill made a muddled situation worse responding to a New York Times report suggesting it might get a refund. GE now says it has a small tax liability for 2010.
5 Ways GE Plays the Tax Game
GE is in a class by itself when it comes to paring its tax rate well below the top U.S. corporate rate of 35 percent – sometimes into the single digits – using an array of strategies that include hiring top tax experts from IRS and Treasury.
Late Settlement Averts First Jury Test For Allegations Against General Electric’s Omniscan
The last-minute deal keeps confidential company documents that could shed new light on claims that GE’s drug, used to enhance MRIs, caused a crippling disease in patients with bad kidneys and that the company hid its risks
General Electric Faces First Jury Test in Omniscan Litigation
An elderly Minnesota woman and her husband claim General Electric hid the risks of the company’s MRI drug Omniscan, causing her to contract a crippling disease.
General Electric Tapped Fed To Borrow $16 Billion
General Electric Co. borrowed $16 billion through a Federal Reserve Board rescue program in the fall of 2008, even as the blue-ribbon company enjoyed the highest credit rating available at the time.
FDA Acts to Restrict GE’s Omniscan MRI Drug, and Two Others
In a setback for GE Healthcare, the U.S. Food and Drug Administration has announced new labeling requirements that ban use of the contrast agent Omniscan and two other drugs in patients with severe kidney disease, who could be at risk of a crippling and fatal disease.
GE Violated Danish Drug Reporting Law in Omniscan Case
Danish drug regulators concluded in a ruling last month that GE's health care unit failed to promptly and completely inform regulators about a patient who died after experiencing adverse effects from the company's MRI drug Omniscan. Though that's a violation of Danish law, the regulators said the statute of limitations had expired and they wold pursue no further action.
Judge Opens Door to Case Against General Electric’s Omniscan
A ruling by a Cleveland judge will allow most of the plaintiffs' expert witnesses to testify about the MRI drug Omniscan. The ruling covers hundreds of lawsuits against General Electric’s health care unit.